Загрузка...
Kidney involvement in COVID-19 and rationale for extracorporeal therapies
The prevalence of direct kidney involvement in novel coronavirus disease (COVID-19) is low, but such involvement is a marker of multiple organ dysfunction and severe disease. Here, we explore potential pathways of kidney damage and discuss the rationale for extracorporeal support with various blood...
Сохранить в:
| Опубликовано в: : | Nat Rev Nephrol |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group UK
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7144544/ https://ncbi.nlm.nih.gov/pubmed/32273593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41581-020-0284-7 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|